The difference and the transition of indication for adult living donor liver transplantation between the West and the East.
In the last 10 years, adult living donor liver transplantation (ALDLT) has evolved in many countries of the world. Relative to cadaver liver transplantation, a living donor can curtail the time awaiting transplantation. However, the indication for ALDLT is still different between the West and the East. This article collects recent published literature on the indications for ALDLT in the West and East from 3 aspects: hepatocellular carcinoma (HCC), cirrhosis, and acute hepatic failure (AHF). The difference of ethics for ALDLT between the West and the East is also investigated. We sought to formulate the indications for ALDLT based upon the condition of our country and verified by ethical committees.
Bo
W T
WT
Division of Liver Transplantation, West China Hospital, West China Medical School of Sichuan University, Chengdu, China.
Yan
L N
LN
D000328:Adult; D002102:Cadaver; D006528:Carcinoma, Hepatocellular / Q000601:surgery*; D002681:China / Q000453:epidemiology; D003469:Culture; D004992:Ethics, Medical; D005843:Geography; D006801:Humans; D008103:Liver Cirrhosis / Q000453:epidemiology / Q000601:surgery; D017093:Liver Failure / Q000601:surgery; D008113:Liver Neoplasms / Q000453:epidemiology / Q000601:surgery*; D016031:Liver Transplantation / Q000502:physiology* / Q000706:statistics & numerical data; D019520:Living Donors / Q000706:statistics & numerical data; D018579:Patient Selection; D017741:Survivors